PPT-Data Source: CROWNWeb clinical extracts for December 2013. Panel a: Dialysis patients

Abbreviations ESRD endstage renal disease HD hemodialysis Hgb hemoglobin Kt V see Glossary PD peritoneal dialysis URR urea reduction ratio VA vascular access vol 2 Figure . O. bjectives. Understand functioning of peritoneal dialysis and haemodialysis. List and understand infection-associated risks for PD and HD from specific organisms/specific procedures. Understand and be able to design infection prevention and control measures for PD and HD patients. August 22, 2013 With CROWNWeb Outreach, Communication, and Training a nd CROWN Data Discrepancy Support CROWNWeb Updates, Notifications and Accretions, and FAQs 8/22/2013 O 2 Janis Grady, RHIT, CPH What Matters, and What Matters to our Patients. Alan S. Kliger MD. Clinical Professor of Medicine. Yale School of Medicine. What is “Quality” ?. Depends on who defines it. Clinician’s View: Best outcomes. What Matters, and What Matters to our Patients. Alan S. Kliger MD. Clinical Professor of Medicine. Yale School of Medicine. What is “Quality” ?. Depends on who defines it. Clinician’s View: Best outcomes. Abbreviations. : ESRD, end-stage renal disease; HD, hemodialysis. ; . Hgb. , hemoglobin; . Kt. /V, see Glossary; PD, peritoneal dialysis; URR, urea reduction ratio; VA, vascular access.. vol 2 Figure . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 5.1 Adjusted all-cause mortality by treatment modality (a) overall, dialysis, and transplant, and (b) hemodialysis and peritoneal dialysis, for period-prevalent patients, 2001-2015 . 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 2.1 ESRD clinical indicator levels among prevalent hemodialysis versus peritoneal dialysis patients in CROWNWeb data, May 2016: (a) percentage of patients meeting clinical care guidelines for dialysis adequacy; (b) percent distribution of Hgb levels; (c) percentage of patients with serum calcium >10.2 mg/. Figure . 4.1 . Vascular access use at hemodialysis initiation, . from . the ESRD Medical Evidence form (CMS 2728), 2005-2013. Vol 2, ESRD, . Ch. 4. 2. 3. AV. fistula. AV graft. Catheter with maturing fistula. CROWNWeb. for December 2014, restricted to patients as follows: Panel a: Dialysis patients initiating treatment for ESRD at least 1 year prior to December 1, 2014, and who were alive through December 31, 2014. The Serbian trial on blood GSTP as novel biomarker of dialysis adequacy and dosage . Sanja Simi. ć. -Ogrizovi. ć. Clinic of nephrology CCS . Medical faculty, University of Belgrade . Belgrade, Serbia. Figure . 13.1 . Geographic variations in the incidence of treated ESRD . per . million population, by country, 2013. Vol 2, ESRD, . Ch. 13. 2. Data . Source. : . Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. All rates are unadjusted. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Belgium do not include patients younger than 20. Data for Indonesia represent the West Java region. Data for France include 22 regions. Data for Spain include 18 of 19 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking.. Tx. , transplant.. Figure . 8.1 . Number of (a) incident and (b) December 31 point prevalent ESRD . pediatric . patients (aged 0–21 years), by modality, 1996-2013. Vol 2, ESRD, . Ch. 8. 2. Incident. Hosp. -based, hospital-based dialysis centers; . Indep. , independent dialysis providers; SDO, small dialysis organizations.. . Figure . 10.1 Dialysis unit counts, by unit affiliation, 2010–2013. Vol 2, ESRD, . ANZDATA Registry 46. th. Annual Report. Data to 31-Dec-2022. Chapter 2 - Graphs. Figure 2.1.1 Prevalent KRT Patient Numbers - Australia - 31 December 2022. Figure 2.1.2 Prevalent KRT Patients Per Million Population - Australia - 31 December 2022.